Literature DB >> 33060108

Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.

Zuguang Gu1,2, Charles D Imbusch3, Martin R Sprick4,5, Andreas Trumpp6,5,7, Elisa Espinet6,5,7, Nathalia A Giese8, Magdalena Büscher4,5, Mariam Safavi4,5, Silke Weisenburger4,5, Corinna Klein4, Vanessa Vogel4, Mattia Falcone4,5, Jacob Insua-Rodríguez4,5, Manuel Reitberger4,5, Vera Thiel4,5, Steffi O Kossi4, Alexander Muckenhuber9, Karnjit Sarai10, Alex Y L Lee10, Elyne Backx11, Soheila Zarei10, Matthias M Gaida12,13, Manuel Rodríguez-Paredes14, Elisa Donato4,5, Hsi-Yu Yen9, Roland Eils2,15,16, Matthias Schlesner1, Nicole Pfarr9, Thilo Hackert8, Christoph Plass17, Benedikt Brors7,3, Katja Steiger7,9, Dieter Weichenhan2, H Efsun Arda18, Ilse Rooman11, Janel L Kopp10, Oliver Strobel8,19, Wilko Weichert7,9.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive desmoplasia, which challenges the molecular analyses of bulk tumor samples. Here we FACS-purified epithelial cells from human PDAC and normal pancreas and derived their genome-wide transcriptome and DNA methylome landscapes. Clustering based on DNA methylation revealed two distinct PDAC groups displaying different methylation patterns at regions encoding repeat elements. Methylationlow tumors are characterized by higher expression of endogenous retroviral transcripts and double-stranded RNA sensors, which lead to a cell-intrinsic activation of an interferon signature (IFNsign). This results in a protumorigenic microenvironment and poor patient outcome. Methylationlow/IFNsignhigh and Methylationhigh/IFNsignlow PDAC cells preserve lineage traits, respective of normal ductal or acinar pancreatic cells. Moreover, ductal-derived Kras G12D/Trp53 -/- mouse PDACs show higher expression of IFNsign compared with acinar-derived counterparts. Collectively, our data point to two different origins and etiologies of human PDACs, with the aggressive Methylationlow/IFNsignhigh subtype potentially targetable by agents blocking intrinsic IFN signaling. SIGNIFICANCE: The mutational landscapes of PDAC alone cannot explain the observed interpatient heterogeneity. We identified two PDAC subtypes characterized by differential DNA methylation, preserving traits from normal ductal/acinar cells associated with IFN signaling. Our work suggests that epigenetic traits and the cell of origin contribute to PDAC heterogeneity.This article is highlighted in the In This Issue feature, p. 521. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33060108      PMCID: PMC9216338          DOI: 10.1158/2159-8290.CD-20-1202

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  122 in total

1.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

2.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

Authors:  Berna C Özdemir; Tsvetelina Pentcheva-Hoang; Julienne L Carstens; Xiaofeng Zheng; Chia-Chin Wu; Tyler R Simpson; Hanane Laklai; Hikaru Sugimoto; Christoph Kahlert; Sergey V Novitskiy; Ana De Jesus-Acosta; Padmanee Sharma; Pedram Heidari; Umar Mahmood; Lynda Chin; Harold L Moses; Valerie M Weaver; Anirban Maitra; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

3.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

4.  Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.

Authors:  Volker Hovestadt; David T W Jones; Simone Picelli; Wei Wang; Marcel Kool; Paul A Northcott; Marc Sultan; Katharina Stachurski; Marina Ryzhova; Hans-Jörg Warnatz; Meryem Ralser; Sonja Brun; Jens Bunt; Natalie Jäger; Kortine Kleinheinz; Serap Erkek; Ursula D Weber; Cynthia C Bartholomae; Christof von Kalle; Chris Lawerenz; Jürgen Eils; Jan Koster; Rogier Versteeg; Till Milde; Olaf Witt; Sabine Schmidt; Stephan Wolf; Torsten Pietsch; Stefan Rutkowski; Wolfram Scheurlen; Michael D Taylor; Benedikt Brors; Jörg Felsberg; Guido Reifenberger; Arndt Borkhardt; Hans Lehrach; Robert J Wechsler-Reya; Roland Eils; Marie-Laure Yaspo; Pablo Landgraf; Andrey Korshunov; Marc Zapatka; Bernhard Radlwimmer; Stefan M Pfister; Peter Lichter
Journal:  Nature       Date:  2014-05-18       Impact factor: 49.962

5.  Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer.

Authors:  M H Schüssler; A Skoudy; F Ramaekers; F X Real
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

6.  LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.

Authors:  Wanqiang Sheng; Martin W LaFleur; Thao H Nguyen; Sujun Chen; Ankur Chakravarthy; Jake Ryan Conway; Ying Li; Hao Chen; Henry Yang; Pang-Hung Hsu; Eliezer M Van Allen; Gordon J Freeman; Daniel D De Carvalho; Housheng Hansen He; Arlene H Sharpe; Yang Shi
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

7.  Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns.

Authors:  Martin Enge; H Efsun Arda; Marco Mignardi; John Beausang; Rita Bottino; Seung K Kim; Stephen R Quake
Journal:  Cell       Date:  2017-09-28       Impact factor: 41.582

8.  The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium.

Authors:  Christoph Plass; Hellmut G Augustin; Katharina Schlereth; Dieter Weichenhan; Tobias Bauer; Tina Heumann; Evangelia Giannakouri; Daniel Lipka; Samira Jaeger; Matthias Schlesner; Patrick Aloy; Roland Eils
Journal:  Elife       Date:  2018-05-11       Impact factor: 8.140

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data.

Authors:  Andrew E Teschendorff; Francesco Marabita; Matthias Lechner; Thomas Bartlett; Jesper Tegner; David Gomez-Cabrero; Stephan Beck
Journal:  Bioinformatics       Date:  2012-11-21       Impact factor: 6.937

View more
  22 in total

1.  Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells.

Authors:  Evan R Abt; Thuc M Le; Amanda M Dann; Joseph R Capri; Soumya Poddar; Vincent Lok; Luyi Li; Keke Liang; Amanda L Creech; Khalid Rashid; Woosuk Kim; Nanping Wu; Jing Cui; Arthur Cho; Hailey Rose Lee; Ethan W Rosser; Jason M Link; Johannes Czernin; Ting-Ting Wu; Robert Damoiseaux; David W Dawson; Timothy R Donahue; Caius G Radu
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.423

2.  TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer.

Authors:  Mengyu Tu; Lukas Klein; Elisa Espinet; Theodoros Georgomanolis; Florian Wegwitz; Xiaojuan Li; Laura Urbach; Adi Danieli-Mackay; Stefan Küffer; Kamil Bojarczuk; Athanasia Mizi; Ufuk Günesdogan; Björn Chapuy; Zuguang Gu; Albrecht Neesse; Uday Kishore; Philipp Ströbel; Elisabeth Hessmann; Stephan A Hahn; Andreas Trumpp; Argyris Papantonis; Volker Ellenrieder; Shiv K Singh
Journal:  Nat Cancer       Date:  2021-11-15

Review 3.  Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer.

Authors:  Lennart Versemann; Elisabeth Hessmann; Maria Ulisse
Journal:  Visc Med       Date:  2021-11-19

Review 4.  Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes.

Authors:  Shilpa Patil; Yan Dou; Janel L Kopp
Journal:  Visc Med       Date:  2021-12-27

5.  Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.

Authors:  Kenneth L Pitter; Olivera Grbovic-Huezo; Simon Joost; Anupriya Singhal; Melissa Blum; Katherine Wu; Matilda Holm; Alexander Ferrena; Arjun Bhutkar; Anna Hudson; Nicolas Lecomte; Elisa de Stanchina; Ronan Chaligne; Christine A Iacobuzio-Donahue; Dana Pe'er; Tuomas Tammela
Journal:  Cancer Res       Date:  2022-10-04       Impact factor: 13.312

6.  Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246.

Authors:  Xiaolei Zhou; Gema Sanz Santos; Yue Zhan; Mariana M S Oliveira; Shiva Rezaei; Madhurendra Singh; Sylvain Peuget; Lisa S Westerberg; John Inge Johnsen; Galina Selivanova
Journal:  Br J Cancer       Date:  2022-09-22       Impact factor: 9.075

7.  TERT activates endogenous retroviruses to promote an immunosuppressive tumour microenvironment.

Authors:  Jian Mao; Qian Zhang; Yaxiang Wang; Yang Zhuang; Lu Xu; Xiaohe Ma; Di Guan; Junzhi Zhou; Jiang Liu; Xiaoying Wu; Qian Liang; Miao Wang; Yu-Sheng Cong
Journal:  EMBO Rep       Date:  2022-02-02       Impact factor: 8.807

Review 8.  Epigenetic Alterations in Pancreatic Cancer Metastasis.

Authors:  Sarah S Wang; Jihao Xu; Keely Y Ji; Chang-Il Hwang
Journal:  Biomolecules       Date:  2021-07-22

9.  Gα15 in early onset of pancreatic ductal adenocarcinoma.

Authors:  Giulio Innamorati; Thomas M Wilkie; Giorgio Malpeli; Salvatore Paiella; Silvia Grasso; Borislav Rusev; Biagio Eugenio Leone; Maria Teresa Valenti; Luca Dalle Carbonare; Samuele Cheri; Alice Giacomazzi; Marco Zanotto; Vanessa Guardini; Michela Deiana; Donato Zipeto; Michela Serena; Marco Parenti; Francesca Guzzi; Rita Teresa Lawlor; Giovanni Malerba; Antonio Mori; Giuseppe Malleo; Luca Giacomello; Roberto Salvia; Claudio Bassi
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

10.  Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.

Authors:  Ruiyu Li; Yangzhige He; Hui Zhang; Jing Wang; Xiaoding Liu; Hangqi Liu; Huanwen Wu; Zhiyong Liang
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.